T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients

被引:44
作者
Satoh, Jun-ichi
Nakanishi, Megumi
Koike, Fumiko
Onoue, Hiroyuki
Aranami, Toshimasa
Yamamoto, Toshiyuki
Kawai, Mitsuru
Kikuchi, Seiji
Nomura, Kyoulchi
Yokoyama, Kazumasa
Ota, Kohei
Salto, Toshiro
Ohta, Masayuki
Miyake, Sachiko
Kanda, Takashi
Fukazawa, Toshiyuki
Yamamura, Takashi
机构
[1] Natl Inst Neurosci, Dept Immunol, NCNP, Kodaira, Tokyo 1878502, Japan
[2] Natl Ctr Hosp Mental Nervous & Muscular Disorders, NCNP, Kodaira, Tokyo 1878502, Japan
[3] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido 0608638, Japan
[4] Saitama Med Sch, Dept Neurol, Moroyama, Saitama 3500495, Japan
[5] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113841, Japan
[6] Tokyo Womens Med Univ, Dept Neurol, Tokyo 1628666, Japan
[7] Tokyo Med & Dent Univ, Dept Neurol, Tokyo 1138519, Japan
[8] Hokuyukai Neurol Hosp, Sapporo, Hokkaido 0630802, Japan
关键词
gene expression profile; hierarchical clustering analysis; IFN beta responder; microarray; multiple sclerosis; T cells;
D O I
10.1016/j.jneuroim.2006.02.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To clarify the molecular background underlying the heterogeneity of multiple sclerosis (MS), we characterized the gene expression profile of peripheral blood CD3+ T cells isolated from MS and healthy control (CN) subjects by using a cDNA microarray. Among 1258 cDNAs on the array, 286 genes were expressed differentially between 72 untreated Japanese MS patients and 22 age- and sex-matched CN subjects. When this set was used as a discriminator for hierarchical clustering analysis, it identified four distinct subgroups of MS patients and five gene clusters differentially expressed among the subgroups. One of these gene clusters was overexpressed in MS versus CN, and particularly enhanced in the clinically most active subgroup of MS. After 46 of the MS patients were treated with interferon-beta (IF beta-1b) for two years, IFN beta responders were clustered in two of the four MS subgroups. Furthermore, the IFN beta responders differed from nonresponders in the kinetics of IFN-responsive genes at 3 and 6 months after starting IFN beta treatment. These results suggest that T-cell gene expression profiling is valuable to identify distinct subgroups of MS associated with differential disease activity and therapeutic response to IFN beta. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:108 / 118
页数:11
相关论文
共 39 条
[1]   Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activity [J].
Achiron, A ;
Gurevich, M ;
Friedman, N ;
Kaminski, N ;
Mandel, M .
ANNALS OF NEUROLOGY, 2004, 55 (03) :410-417
[2]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[3]   REGULATION OF T-CELL ACTIVATION BY CYTOCHROME-P450 INHIBITORS [J].
AUSSEL, C ;
BREITTMAYER, JP ;
TICCHIONI, M ;
PELASSY, C ;
BERNARD, A .
CELLULAR IMMUNOLOGY, 1994, 155 (02) :436-445
[4]   CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions [J].
Balashov, KE ;
Rottman, JB ;
Weiner, HL ;
Hancock, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6873-6878
[5]   A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes [J].
Baldi, P ;
Long, AD .
BIOINFORMATICS, 2001, 17 (06) :509-519
[6]   CLONING AND CHARACTERIZATION OF A RNASE-L INHIBITOR - A NEW COMPONENT OF THE INTERFERON-REGULATED 2-5A PATHWAY [J].
BISBAL, C ;
MARTINAND, C ;
SILHOL, M ;
LEBLEU, B ;
SALEHZADA, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) :13308-13317
[7]   Multiple sclerosis [J].
Compston, A ;
Coles, A .
LANCET, 2002, 359 (9313) :1221-1231
[8]   INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
DUQUETTE, P ;
GIRARD, M ;
DESPAULT, L ;
DUBOIS, R ;
KNOBLER, RL ;
LUBLIN, FD ;
KELLEY, L ;
FRANCIS, GS ;
LAPIERRE, Y ;
ANTEL, J ;
FREEDMAN, M ;
HUM, S ;
GREENSTEIN, JI ;
MISHRA, B ;
MULDOON, J ;
WHITAKER, JN ;
EVANS, BK ;
LAYTON, B ;
SIBLEY, WA ;
LAGUNA, J ;
KRIKAWA, J ;
PATY, DW ;
OGER, JJ ;
KASTRUKOFF, LF ;
MOORE, GRW ;
HASHIMOTO, SA ;
MORRISON, W ;
NELSON, J ;
GOODIN, DS ;
MASSA, SM ;
GUTTERIDGE, E ;
ARNASON, BGW ;
NORONHA, A ;
REDER, AT ;
MARTIA, R ;
EBERS, GC ;
RICE, GPA ;
LESAUX, J ;
JOHNSON, KP ;
PANITCH, HS ;
BEVER, CT ;
CONWAY, K ;
WALLENBERG, JC ;
BEDELL, L ;
VANDENNOORT, S ;
WEINSHENKER, B ;
WEISS, W ;
REINGOLD, S ;
PACHNER, A ;
TAYLOR, W .
NEUROLOGY, 1993, 43 (04) :655-661
[9]   Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult [J].
Graumann, U ;
Reynolds, R ;
Steck, AJ ;
Schaeren-Wiemers, N .
BRAIN PATHOLOGY, 2003, 13 (04) :554-573
[10]  
Gveric D, 1999, NEUROPATH APPL NEURO, V25, P215